UCSF

Tagged: Research

Impact of Curriculum Transformation Awards given for assessing new PharmD curriculum

Impact Awards support new ways of determining how the new PharmD curriculum is working, according to Vice Dean Sharon Youmans.

Studies on adolescent drug abuse, anti­de­pres­sants in the ER, and complications from heart pumps take top honors at annual seminar

Research on topics ranging from drug abuse to heart pump complications took top honors at the Department of Clinical Pharmacy’s 21st annual Spring Research Seminar.

Study shows promise for hormonal contraception services in the community pharmacy setting

A study shows the potential of hormonal contraceptives at pharmacies in California and Oregon.

2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year

Among all U.S. pharmacy schools, the UCSF School of Pharmacy earned the most research funding from the National Institutes of Health in 2018, totaling nearly $29 million dollars that will support studies spanning the basic to the clinical sciences.

School of Pharmacy emeriti Kollman, Kuntz, and Langridge honored with UCSF Medal

Drug discovery today begins with computation rather than test tube experimentation. Three School of Pharmacy faculty emeriti, Robert Langridge, Irwin “Tack” Kuntz, and the late Peter Kollman, were awarded the UCSF Medal for creating computational tools for drug discovery that are now used worldwide.

Update from the Dean – November 2018

Curriculum transformation, An expanded role, Gaining recognition, Graduate match rate; School of Pharmacy scientists receive UCSF Medal: Founding fathers of drug discovery honored; Beyond drugs, Two artificial pancreas projects, Bringing prosthetics to patients; Beyond drugs, Two artificial...

Arkin receives Ono Pharma Foundation Breakthrough Science Initiative Award

Michelle Arkin, PhD, has received the 2018 Breakthrough Science Initiative Award from the Ono Pharma Foundation to study a class of proteins, called 14-3-3 proteins, known to be involved in various cancers, with the ultimate goal of enabling discoveries that lead to new ways to treat cancer.

The dean advocates for medication lists and pharmacist engagement in patient care

Medical errors are the third leading cause of death in the U.S., trailing cancer and heart disease. Many of those errors can be traced to issues with medications.

Pages